Stay updated on Olaparib Maintenance Retreatment in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Olaparib Maintenance Retreatment in Ovarian Cancer Clinical Trial page.

Latest updates to the Olaparib Maintenance Retreatment in Ovarian Cancer Clinical Trial page
- Check4 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4, with the page displaying Revision: v3.3.4.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedAdded a Locations section including Ontario. Removed Ontario Locations and the HHS Vulnerability Disclosure (revision 3.3.2 to 3.3.3).SummaryDifference0.1%

- Check54 days agoChange DetectedAdded a note that publications are automatically filled from PubMed and may not be about the study, and updated the revision to v3.3.2, replacing the previous PubMed-origin wording. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check61 days agoChange DetectedThe page removed an administrative notice about government funding and NIH operations, which does not affect the study details, results, or participant information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check75 days agoChange DetectedOnly minor formatting and layout tweaks were observed; no core study data or critical page content were changed (e.g., title, NCT number, eligibility criteria, endpoints), and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check104 days agoChange Detected- Updated the page to v3.2.0 and added a government-operational status notice clarifying potential delays and open status of NIH Clinical Center. - Removed the previous version tag v3.1.0.SummaryDifference2%

Stay in the know with updates to Olaparib Maintenance Retreatment in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Olaparib Maintenance Retreatment in Ovarian Cancer Clinical Trial page.